Ind-Swift Laboratories Ltd. — Capital/Financing Update 2025

Mar 18, 2025

==> picture [592 x 99] intentionally omitted <==

Ref: ISLL:CH:2025	Date: 18th March, 2025
Department of Corporate Services,	Department of Corporate Services,
BSE Limited	National Stock Exchange of India Limited,
Phiroze Jeejeebhoy Towers,	Exchange Plaza, 5th Floor
25th Floor, Dalal Street,	Plot No. C/2, G-Block,
Mumbai 400 001	Bandra Kurla Complex, Bandra (E),
	Mumbai 400 051
ISIN: INE915B01019
BSE Scrip Code: 532305	NSE Symbol: INDSWFTLAB

SUBJECT: OUTCOME OF THE MEETING OF THE PREFERENTIAL ISSUE COMMITTEE OF THE BOARD OF DIRECTORS OF IND-SWIFT LABORATORIES LIMITED

Ref: Intimation of allotment of Equity Shares upon conversion of Warrants on preferential basis under the provisions of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018 ("SEBI ICDR Regulations").

Dear Sir/Ma’am,

In continuation to our letter dated August 30, 2024, w.r.t. to allotment of Warrants and in accordance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform your good office that the Preferential Issue Committee of the Board of Directors of Ind-Swift Laboratories Limited (“ the Company ”) at their meeting held today i.e., March 18, 2025, has, inter alia, considered and approved the allotment of 15,32,000 Equity Shares of face value of ₹ 10/- each pursuant to the conversion of 15,32,000 Fully Convertible Warrants (“ Warrants ”), allotted on August 30, 2024, at an issue price of ₹ 121/- each to Zeal Global Opportunities Fund , belonging to the Non-Promoter Category of the Company by way of preferential allotment on a private placement basis.

Consequent to the said allotment, the Paid-up Equity Share Capital of the Company stands increased to ₹60,61,88,600/- (Rupees Sixty Crore Sixty-One Lakh Eighty-Eight Thousand and Six Hundred Only) divided into 6,06,18,860 (Six Crore Six Lakh Eighteen Thousand Eight Hundred and Sixty) Equity Shares of face value of ₹10/- each. The new equity shares so allotted shall rank pari passu with the existing equity shares of the Company in all respects, including the payment of dividend and voting rights.

The information required pursuant to Regulation 30, read with SEBI Master Circular issued vide circular no. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 is enclosed herewith as Annexure A.

The meeting of the Preferential Issue Committee of the Board of Directors was commenced at 5:00 P.M. and concluded at 5:30 P.M.

This is for your information and records.

Thanking you,

Yours faithfully, For & on behalf of IND-SWIFT LABORATORIES LTD.

Pardeep Digitally signed by Pardeep Verma Verma Date: 2025.03.18 17:56:04 +05'30' PARDEEP VERMA VP-CORPORATE AFFAIRS & COMPANY SECRETARY

==> picture [592 x 99] intentionally omitted <==

Annexure – A

Disclosure in respect of the allotment of equity shares pursuant to conversion of warrants, in terms of Regulation 30 and Schedule III of the SEBI Listing Obligations and Disclosure Requirements) Regulations, 2015

S. No.	Particulars Disclosures	Particulars Disclosures
1.	Type of securities proposed to be issued Equity shares with face value of ₹10/- each pursuant to conversion of warrants.
2.	Type of issuance Preferential allotment on private placement basis
3.	Total number of securities proposed to be issued or total amount for which the securities will be issued Allotment of 15,32,000 equity shares of face value ₹10/-each, pursuant to conversion of 15,32,000 warrants, against receipt of the balance subscription amount of ₹ 90.75/- per warrant (i.e. 75% of the issueprice),aggregatingto ₹13,90,29,000/-
	ADDITIONAL INFORMATION IN THE CASE OF THE PREFERENTIAL ISSUE:
4.	Name and number of the Investor(s)	1.) Zeal Global Opportunities Fund
5.	Post allotment of securities- outcome of the subscription	Pursuant to the aforesaid allotment, the issued, subscribed and paid-up share capital of the Company stands increased in the manner as set out in the letter above.
6.	issue price / allotted price (in case of convertibles)	Equity Warrants had been allotted on August 30, 2024, carrying a right to subscribe to one Equity Share per warrant on receipt of amount at the rate of ₹30.25/- per warrant (being 25% of the issue price per warrant). Now, 15,32,000 Equity Shares have been allotted on receipt of balance amount at the rate of ₹90.75/- per warrant (being 75% of the issue price per warrant). Therefore, Issue price is ₹ 121/- per equity share.
7.	in case of convertibles - intimation on conversion of securities or on lapse of the tenure of the instrument	One allottee as mentioned above has exercised its rights and converted their 15,32,000 warrants (out of 40,00,000 warrants) upon receipt of Warrant Exercise Price of ₹90.75 per warrant (being 75% of the issue price). Balance 24,68,000 warrants held by said allottee are eligible for conversion within 18 months from the date of allotment of warrants.